Burrows Scott L

EDGAR CIK 0001853327

Spyre Therapeutics, Inc. - SYRE

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
1
($522,074)
-18,531 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
09/03/2024
09/05/2024
Sell
-18,531 @ $28.17
 ($522,074) 116,422 (-13.73%) Direct